Headline Roundup • May 6th, 2022
FDA Restricts J&J’s COVID-19 Vaccine for Some People Over Blood Clot Risk
Summary from the AllSides News Team
U.S. regulators have strictly limited who can receive the Johnson & Johnson COVID-19 vaccine due to the risk of rare but severe blood clots.
The Food and Drug Administration (FDA) said Thursday that adults should only get the J&J shot if “they would otherwise not receive a COVID-19 vaccine” or if they can't receive one of the mRNA vaccines from Moderna and Pfizer. The shot will now be limited to people ages 18 and older who are medically ineligible for another approved vaccine or who only have access to the J&J vaccine and want one.
U.S. authorities have recommended for months that Americans get Pfizer or Moderna shots instead of J&J’s due to potentially serious side effects. The Moderna and Pfizer vaccines are two-dose vaccines and use mRNA technology; J&J’s single-shot vaccine uses adenovirus technology.
The news was covered by sources across the political spectrum. Left- and center-rated sources placed more emphasis on how rare the blood clot side effects are compared to right-rated sources. Some reports from the left also highlighted an FDA official who said that the "known and potential benefits of the vaccine" still currently outweigh the negatives.
Featured Coverage of this Story
Raul Arboleda/AFP via Getty Images
The U.S. Food and Drug Administration is limiting the use of Johnson and Johnson's Janssen COVID-19 vaccine as a last resort for adults who cannot accept a shot from another manufacturer.
Though the potential benefits of the vaccine outweigh the risks, the FDA said Thursday that it is restricting the use of the Janssen vaccine. It will be limited to individuals 18 and older and medically ineligible for another approved vaccine and to those who only have access to the J&J vaccine and want one, according to an FDA news release.
...
AP Photo/David Zalubowski, File
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans get Pfizer or Moderna shots instead of J&J’s vaccine.
FDA’s vaccine chief Dr. Peter Marks said the agency decided to restrict the vaccine after taking another look at the data on the...
Lucy Nicholson/Reuters
The Food and Drug Administration (FDA) announced on May 5 that it will restrict the use of the Johnson & Johnson COVID-19 vaccine to adults who can’t receive mRNA vaccines, because of the risk of potentially life-threatening side effects with the J&J shot.
The agency said the COVID-19 vaccine can now only be administered to people aged 18 years of age and older who can’t receive either the Moderna or Pfizer vaccines, both of which are two-dose vaccines and use mRNA technology. J&J’s single-shot vaccine uses adenovirus technology.
People 18 and older who...
